Insider Buying: Joint (NASDAQ:JYNT) Major Shareholder Purchases $10,733.10 in Stock

The Joint Corp. (NASDAQ:JYNT – Get Free Report) major shareholder Charles Jobson purchased 1,614 shares of Joint stock in a transaction on Tuesday, November 17th. The shares were purchased at an average cost of $6.65 per share, with a total value of $10,733.10. Following the transaction, the insider owned 2,036,071 shares in the company, valued at approximately $13,539,872.15. The trade was a 0.08% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Joint Trading Down 3.7%

Shares of JYNT opened at $6.19 on Friday. The stock has a market capitalization of $84.74 million, a price-to-earnings ratio of 30.95 and a beta of 1.16. The Joint Corp. has a 12 month low of $6.19 and a 12 month high of $10.67. The firm has a fifty day simple moving average of $7.35 and a 200 day simple moving average of $8.37.

Joint (NASDAQ:JYNT – Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.02. Joint had a net margin of 4.81% and a return on equity of 22.11%. The firm had revenue of $13.55 million for the quarter, compared to analyst estimates of $14.85 million. As a group, research analysts predict that The Joint Corp. will post 0.31 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

JYNT has been the topic of several recent analyst reports. B. Riley Financial lowered their price objective on shares of Joint from $9.00 to $8.00 and set a “neutral” rating on the stock in a research note on Monday, November 9th. Wall Street Zen cut Joint from a “buy” rating to a “hold” rating in a research report on Saturday, November 14th. Finally, Weiss Ratings upgraded shares of Joint from a “sell (d)” rating to a “sell (d+)” rating in a research report on Wednesday, November 11th. Two analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Reduce” and a consensus price target of $8.00.

Read Our Latest Research Report on JYNT

Institutional Investors Weigh In On Joint

A number of hedge funds and other institutional investors have recently bought and sold shares of JYNT. Marshall Wace LLP increased its stake in shares of Joint by 372.2% in the third quarter. Marshall Wace LLP now owns 251,089 shares of the company’s stock valued at $1,858,000 after buying an additional 197,916 shares during the period. R Squared Ltd grew its stake in shares of Joint by 40.3% in the third quarter. R Squared Ltd now owns 14,910 shares of the company’s stock worth $110,000 after purchasing an additional 4,284 shares during the last quarter. Skylands Capital LLC grew its stake in shares of Joint by 5.6% in the third quarter. Skylands Capital LLC now owns 946,045 shares of the company’s stock worth $7,001,000 after purchasing an additional 50,473 shares during the last quarter. Squarepoint Ops LLC grew its stake in shares of Joint by 35.5% in the second quarter. Squarepoint Ops LLC now owns 105,467 shares of the company’s stock worth $926,000 after purchasing an additional 27,633 shares during the last quarter. Finally, Susquehanna International Group LLP increased its stake in shares of Joint by 161.3% in the second quarter. Susquehanna International Group LLP now owns 43,138 shares of the company’s stock valued at $379,000 after buying an additional 26,626 shares during the period. Institutional investors own 76.88% of the company’s stock.

About Joint

(Get Free Report)

The Joint Corp. operates and franchises The Joint Chiropractic, a network of clinics providing chiropractic care in the United States. Its clinics offer services such as spinal adjustments and other chiropractic treatments focused on musculoskeletal health and wellness. The company’s business model emphasizes convenient access to care, with options that include walk-in visits and recurring membership plans. The Joint Corp. was established in 2010 and is headquartered in Scottsdale, Arizona.

Further Reading

Insider Buying and Selling by Quarter for Joint (NASDAQ:JYNT)

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.